The 24,000 sqft facility, located within a mile of the company’s early-phase oral drug product site, has been established to support clinical studies in Phases I-III
Catalent, a provider of clinical supply services, has announced the opening of a facility in San Diego, in response to increased demand from pharmaceutical and biopharmaceutical customers for integrated development, clinical packaging, and distribution solutions on the US West Coast. The facility marks the latest expansion of the company’s global clinical supply network, following the opening of a site in Japan in October.
The 24,000 sqft facility, located within a mile of the company’s early-phase oral drug product site, has been established to support clinical studies in Phases I-III. The site offers services including supply management, primary and secondary packaging and labelling, storage, distribution, returns and destruction.
“Our new full-service San Diego supply facility is strategically located to work in tandem with our development center and serve customers not only on the West Coast of the U.S. and Canada, but across the world,” said Kristen DeVito, Vice President of Operations, Clinical Supply Services, North America at Catalent. “In addition to investments we have made across our global network, the site is part of a wider strategy to provide local, integrated supply services, which offer a supply chain advantage as the world adjusts to the impact of the pandemic and its inherent logistical challenges.”